CS logo
small CS logo
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute

Torino, TO, Italy

About Dipartimento di Biotecnologie Molecolari e Scienze per la Salute


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Dipartimento di Biotecnologie Molecolari e Scienze per la Salute


During the past decade, Dipartimento di Biotecnologie Molecolari e Scienze per la Salute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Dipartimento di Biotecnologie Molecolari e Scienze per la Salute


According to Clinical.Site data, the most researched conditions in "Dipartimento di Biotecnologie Molecolari e Scienze per la Salute" are "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Dipartimento di Biotecnologie Molecolari e Scienze per la Salute" in a lesser frequency.

Clinical Trials Intervention Types at Dipartimento di Biotecnologie Molecolari e Scienze per la Salute


Most popular intervention types in "Dipartimento di Biotecnologie Molecolari e Scienze per la Salute" are "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Daratumumab" (1 trials), "Dexamethasone" (1 trials), "Evaluation of patients resistance to immunotherapies in Multiple Myeloma" (1 trials), "Lenalidomide" (1 trials) and "Melphalan" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Dipartimento di Biotecnologie Molecolari e Scienze per la Salute


The vast majority of trials in "Dipartimento di Biotecnologie Molecolari e Scienze per la Salute" are 2 trials for "All" genders.

Clinical Trials Status at Dipartimento di Biotecnologie Molecolari e Scienze per la Salute


Currently, there are NaN active trials in "Dipartimento di Biotecnologie Molecolari e Scienze per la Salute". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Dipartimento di Biotecnologie Molecolari e Scienze per la Salute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".